Physician profile
Mary A Evers
NPI 1053533026
$1,383.42
in general payments reported to CMS, 2019-2025
21 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $153 · 2021: $114 · 2022: $258 · 2023: $67.97 · 2024: $209 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $144.18 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $108.41 | 2019-2024 | Dupixent |
| Genzyme Corporation | $105.71 | 2021-2025 | |
| Ucb, INC. | $104.55 | 2021-2025 | Bimzelx |
| Pfizer INC. | $102.22 | 2019-2021 | |
| Janssen Biotech, INC. | $83.98 | 2019 | |
| Sebela Pharmaceuticals INC. | $80.88 | 2019 | |
| Abbvie INC. | $80.76 | 2019-2024 | |
| Incyte Corporation | $64.83 | 2022-2023 | Opzelura |
| Lilly USA, LLC | $63.32 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $62.73 | 2022-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $62.35 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $61.01 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $59.75 | 2024-2025 | |
| Biofrontera INC. | $39.17 | 2020-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $36.57 | 2022-2024 | |
| Aclaris Therapeutics, INC. | $31.74 | 2019 | |
| Leo Pharma INC. | $29.13 | 2019-2020 | |
| Glenmark Therapeutics INC. | $27.00 | 2019 | |
| Journey Medical Corporation | $19.42 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $15.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Evers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.